Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2020
Committee Review
Floor Vote
Governor
Introduced Mar 16, 2020
Last action Jun 3, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
1
Committee
1
Feb 9, 2021
Upper · Passed
Reported out of Senate Committee with Amendments, 2nd Reading
upper
Mar 16, 2020
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 2035
Scope: NJ
Hi! I can help you understand S 2035. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline